McIlrath & Eck’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.4K | Hold |
685
| – | – | ﹤0.01% | 495 |
|
|
2025
Q4 | $54.1K | Hold |
685
| – | – | 0.01% | 338 |
|
|
2025
Q3 | $54.8K | Hold |
685
| – | – | 0.01% | 301 |
|
|
2025
Q2 | $62.3K | Hold |
685
| – | – | 0.01% | 272 |
|
|
2025
Q1 | $64.2K | Hold |
685
| – | – | 0.01% | 267 |
|
|
2024
Q4 | $62.3K | Hold |
685
| – | – | 0.01% | 265 |
|
|
2024
Q3 | $71.1K | Hold |
685
| – | – | 0.01% | 240 |
|
|
2024
Q2 | $66.5K | Hold |
685
| – | – | 0.01% | 238 |
|
|
2024
Q1 | $61.7K | Sell |
685
-51
| -7% | -$4.32K | 0.01% | 242 |
|
|
2023
Q4 | $58.7K | Hold |
736
| – | – | 0.01% | 240 |
|
|
2023
Q3 | $52.3K | Hold |
736
| – | – | 0.01% | 249 |
|
|
2023
Q2 | $56.7K | Hold |
736
| – | – | 0.01% | 232 |
|
|
2023
Q1 | $55.3K | Sell |
736
-38
| -5% | -$2.83K | 0.01% | 232 |
|
|
2022
Q4 | $61K | Buy |
774
+38
| +5% | +$2.85K | 0.02% | 214 |
|
|
2022
Q3 | $52K | Hold |
736
| – | – | 0.01% | 230 |
|
|
2022
Q2 | $59K | Sell |
736
-38
| -5% | -$2.97K | 0.02% | 208 |
|
|
2022
Q1 | $59K | Hold |
774
| – | – | 0.02% | 213 |
|
|
2021
Q4 | $66K | Sell |
774
-246
| -24% | -$19.2K | 0.02% | 206 |
|
|
2021
Q3 | $77K | Hold |
1,020
| – | – | 0.02% | 174 |
|
|
2021
Q2 | $83K | Sell |
1,020
-131
| -11% | -$10.7K | 0.03% | 180 |
|
|
2021
Q1 | $91K | Buy |
1,151
+261
| +29% | +$20.5K | 0.03% | 134 |
|
|
2020
Q4 | $76K | Buy |
890
+325
| +58% | +$26.9K | 0.03% | 131 |
|
|
2020
Q3 | $44K | Buy |
+565
| New | +$43.1K | 0.02% | 158 |
|
|
2019
Q4 | – | Sell |
-47
| Closed | -$3K | – | 636 |
|
|
2019
Q3 | $3K | Hold |
47
| – | – | ﹤0.01% | 516 |
|
|
2019
Q2 | $3K | Hold |
47
| – | – | ﹤0.01% | 522 |
|
|
2019
Q1 | $3K | Hold |
47
| – | – | ﹤0.01% | 522 |
|
|
2018
Q4 | $3K | Buy |
+47
| New | +$2.94K | ﹤0.01% | 435 |
|
|
2018
Q3 | – | Sell |
-60
| Closed | -$4K | – | 539 |
|
|
2018
Q2 | $4K | Buy |
+60
| New | +$3.92K | ﹤0.01% | 385 |
|
|
2018
Q1 | – | Sell |
-60
| Closed | -$5K | – | 485 |
|
|
2017
Q4 | $5K | Buy |
+60
| New | +$4.38K | ﹤0.01% | 363 |
|
Other funds holding CL
McIlrath & Eck's CL Position: Q1 2026 in Review
McIlrath & Eck held its Colgate-Palmolive (CL) position steady in Q1 2026 at 685 shares worth $58.4K. The position accounts for ﹤0.01% of the portfolio, ranked #495.
McIlrath & Eck first reported a position in CL in Q4 2017 and has held it in 29 quarters since. The position peaked at $91K in Q1 2021. 1,959 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- McIlrath & Eck held 685 shares of Colgate-Palmolive worth $58.4K as of Q1 2026.
- McIlrath & Eck left its Colgate-Palmolive share count unchanged in Q1 2026.
- Colgate-Palmolive made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #495 holding.
- McIlrath & Eck first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 29 quarters since.
- McIlrath & Eck's Colgate-Palmolive position peaked at $91K in Q1 2021.
- 1,959 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.